New Australian life sciences investment fund could have spin-off benefits to New Zealand

New Australian life sciences investment fund could have spin-off benefits to New Zealand
Fiona Rotherham
By Fiona Rotherham Dec. 15 (BusinessDesk) - Australia’s largest life science venture fund, the Medical Research Commercialisation Fund, just got bigger with the Australian government’s launch of a A$500 million Biomedical Translation Fund aimed at making the country a global leader in commercialising biomedical discoveries. The BTF pool of public and private capital will be managed by three venture capital fund managers with different pots of money. Some A$230 million has gone to Brandon Capital which manages the MRCF, a collaborative str...